Selected NIAID Science News Highlights of 2018 As 2019 approaches, a new slideshow highlights selected NIAID science news from the past year. NIAID scientists and NIAID-supported researchers made significant advances in understanding and treating allergic, immunologic, autoimmune and infectious diseases. Other work accelerated progress toward development of novel, safe and effective vaccines, including a universal flu vaccine. In addition, NIAID issued a strategic plan to reinvigorate research on tuberculosis, the leading infectious cause of death worldwide. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107